Keyphrases
AKT/mammalian Target of Rapamycin
100%
Inhibits Proliferation
100%
Colorectal Cancer
67%
Phosphoinositide 3-kinase (PI3K)
57%
Mammalian Target of Rapamycin Signaling Pathway
50%
AKT2
50%
NFATc1
50%
Triptolide
50%
Virgin Abdomen
50%
AKT1
50%
Histone Deacetylase Inhibitor (HDACi)
50%
Cytokine Receptor
50%
Curcumin
50%
Nuclear Factor of Activated T Cells
50%
Translational Research
50%
Nonoperative Management
50%
T Cell Signaling
50%
Human Colorectal Cancer
50%
PTEN Expression
50%
Colorectal Carcinoma
50%
Expression Pattern
50%
Neurotensin Receptor
50%
Water Use
50%
Water-soluble Contrast
50%
Colon Cancer Cells
50%
Intestinal Obstruction
50%
Gastric Cancer
50%
Gastric Malignancy
50%
Cell Cycle Regulators
50%
Receptor Subtypes
50%
Intestinal Cell Differentiation
50%
Immunology
50%
Mammalian Target of Rapamycin Signaling
50%
NTR1
50%
Epigenetic Modification
50%
Glycogen Synthase Kinase 3 (GSK3)
37%
NFATc4
35%
Tyrosine Kinase
25%
Histone Acetylation
25%
DNA Hypermethylation
25%
Helicobacter Pylori Eradication
25%
Expression Level
25%
Gastrointestinal Hormones
25%
Prognostic Implications
25%
Clinical Trials
25%
Drug Target
25%
Oncogene
25%
Colon Tissue
25%
Helicobacter Pylori Infection
25%
Host Genetics
25%
Medicine and Dentistry
Colorectal Carcinoma
100%
Cancer
75%
Cancer Cell
56%
Malignant Neoplasm
55%
Patient History of Surgery
50%
Triptolide
50%
Translational Research
50%
Small Intestine Obstruction
50%
Phosphoinositide 3-Kinase
50%
Cytokine Receptor
50%
Histone Deacetylase Inhibitor
50%
Glycogen Synthase Kinase
50%
Cell Cycle
50%
Neurotensin Receptor
50%
Akt/mTOR Signaling
50%
Abdominal Cancer
50%
Colon Carcinoma
50%
Immunology
33%
Mitogen-Activated Protein Kinase
31%
Surgery
25%
Adhesive Agent
25%
Digestive System Surgery
25%
Case Presentation
25%
Surgical Exploration
25%
Pelvis
25%
Recurrent Disease
25%
Drug Therapy
25%
Abdominal Pain
25%
Meta-Analysis
25%
Prevalence
25%
Mechanistic Target of Rapamycin
25%
Colon
25%
Promoter Region
18%
Messenger RNA
18%
Protein Tyrosine Kinase
16%
Helicobacter Infection
16%
Clinical Trial
16%
Growth Factor
16%
Proto Oncogene
16%
Gastrointestinal Polypeptide
16%
Drug Delivery System
16%
DNA Methylation
16%
Histone
16%
Cancer Prognosis
16%
Cancer Research
16%
Deacetylation
16%
Colon Tissue
12%
Mitogen Activated Protein Kinase 6
12%
Colon Mucosa
12%
Phosphotransferase
12%
Pharmacology, Toxicology and Pharmaceutical Science
Colorectal Carcinoma
100%
Malignant Neoplasm
61%
Mammalian Target of Rapamycin
50%
Patient History of Surgery
50%
Phosphatidylinositol 3 Kinase
50%
Triptolide
50%
Small Intestine Obstruction
50%
Cytokine Receptor
50%
Neurotensin Receptor
50%
Glycogen Synthase Kinase
50%
Histone Deacetylase Inhibitor
50%
Colon Carcinoma
50%
Abdominal Cancer
50%
Mitogen Activated Protein Kinase
31%
Therapeutic Use
25%
Prevalence
25%
Recurrent Disease
25%
Adhesive Agent
25%
Abdominal Pain
25%
Messenger RNA
18%
Histone
16%
Helicobacter Infection
16%
Cancer Prognosis
16%
Growth Factor
16%
Drug Delivery System
16%
Protein Tyrosine Kinase
16%
Clinical Trial
16%
Gastrointestinal Polypeptide
16%
Cancer Staging
12%
Mitogen Activated Protein Kinase 6
12%
Neurotensin
12%
Phosphotransferase
12%
Cancer Growth
11%
Vasculotropin
11%
Cyclooxygenase 2
6%
Growth Disorder
6%
Interleukin 8
6%
Butyrate
6%
Phosphotransferase Inhibitor
6%
Thrombin Receptor
5%
Tripterygium wilfordii
5%
Phytochemical
5%
Tumor Necrosis Factor Receptor
5%
Antiinflammatory Agent
5%
Metastasis
5%
Tumor Invasion
5%
Chinese Herb
5%
Cycline
5%
Receptor
5%